X. Rosa Ma,Stephanie D. Conley,Michael Kosicki,Danila Bredikhin,Ran Cui,Steven Tran,Maya U. Sheth,Wei-Lin Qiu,Sijie Chen,Soumya Kundu,Helen Y. Kang,Dulguun Amgalan,Chad J. Munger,Lauren Duan,Katherine Dang,Oriane Matthys Rubio,Shinwan Kany,Siavash Zamirpour,John DePaolo,Arun Padmanabhan,Birth Defects Research Laboratory,Jeffrey Olgin,Scott Damrauer,Robin Andersson,Mingxia Gu,James R. Priest,Thomas Quertermous,Xiaojie Qiu,Marlene Rabinovitch,Axel Visel,Len Pennacchio,Anshul Kundaje,Ian A. Glass,Casey A. Gifford,James P. Pirruccello,William R. Goodyer,Jesse M. Engreitz

Abstract:Congenital heart defects (CHD) arise in part due to inherited genetic variants that alter genes and noncoding regulatory elements in the human genome. These variants are thought to act during fetal development to influence the formation of different heart structures. However, identifying the genes, pathways, and cell types that mediate these effects has been challenging due to the immense diversity of cell types involved in heart development as well as the superimposed complexities of interpreting noncoding sequences. As such, understanding the molecular functions of both noncoding and coding variants remains paramount to our fundamental understanding of cardiac development and CHD. Here, we created a gene regulation map of the healthy human fetal heart across developmental time, and applied it to interpret the functions of variants associated with CHD and quantitative cardiac traits. We collected single-cell multiomic data from 734,000 single cells sampled from 41 fetal hearts spanning post-conception weeks 6 to 22, enabling the construction of gene regulation maps in 90 cardiac cell types and states, including rare populations of cardiac conduction cells. Through an unbiased analysis of all 90 cell types, we find that both rare coding variants associated with CHD and common noncoding variants associated with valve traits converge to affect valvular interstitial cells (VICs). VICs are enriched for high expression of known CHD genes previously identified through mapping of rare coding variants. Eight CHD genes, as well as other genes in similar molecular pathways, are linked to common noncoding variants associated with other valve diseases or traits via enhancers in VICs. In addition, certain common noncoding variants impact enhancers with activities highly specific to particular subanatomic structures in the heart, illuminating how such variants can impact specific aspects of heart structure and function. Together, these results implicate new enhancers, genes, and cell types in the genetic etiology of CHD, identify molecular convergence of common noncoding and rare coding variants on VICs, and suggest a more expansive view of the cell types instrumental in genetic risk for CHD, beyond the working cardiomyocyte. This regulatory map of the human fetal heart will provide a foundational resource for understanding cardiac development, interpreting genetic variants associated with heart disease, and discovering targets for cell-type specific therapies.

A genetic and developmental biological approach for a family with complex congenital heart diseases—evidence of digenic inheritance

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

A HAND2 Loss-of-Function Mutation Causes Familial Ventricular Septal Defect and Pulmonary Stenosis

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

Integrative analysis of genomic variants reveals new associations of candidate haploinsufficient genes with congenital heart disease

SOX7 loss-of-function variation as a cause of familial congenital heart disease

A New TBX5 Loss-of-Function Mutation Contributes to Congenital Heart Defect and Atrioventricular Block

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Whole-exome sequencing of pathogenic genes in a family with congenital heart disease: A case report

Novel PITX2c Loss-of-function Mutations Associated with Complex Congenital Heart Disease.

A Novel Nkx2.6 Mutation Associated with Congenital Ventricular Septal Defect

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease

Prevalence and Spectrum of Nkx2.6 Mutations in Patients with Congenital Heart Disease.

Genomic rare variant mechanisms for congenital cardiac laterality defect: A digenic model approach

A Novel NR2F2 Loss-of-function Mutation Predisposes to Congenital Heart Defect.

Identification of <i>SOX18</i> as a New Gene Predisposing to Congenital Heart Disease

Influence of genes and the environment in familial congenital heart defects.

Prenatal Genetic Diagnosis in Three Fetuses With Left Heart Hypoplasia (LHH) From Three Unrelated Families

Transcription factor protein interactomes reveal genetic determinants in heart disease

The complex genetics of hypoplastic left heart syndrome